NuCyRNA Therapeutics
PrivateLast Round
Grant
Jun 12, 2025
Total Funding Raised
$500,000
Company Overview
NuCyRNA Therapeutics is a biotechnology company developing RNA-targeting oligonucleotide therapeutics to address neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuCyRNA Therapeutics Comparables
Compare NuCyRNA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trace Neuroscience | 85% | |
| QurAlis | 76% | |
| Novartis | 68% | |
NuCyRNA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 12, 2025 | ||||
| Seed | Oct 30, 2024 | ||||
| Accelerator | Mar 18, 2024 |
NuCyRNA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Labs | Accelerator |
| Target ALS | Grant |
| Ono Venture Investment, Inc. | Seed |
| Mission BioCapital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 12, 2025
Received grant from Target ALS.
- Oct 30, 2024
$500K round led by Mission BioCapital.
NuCyRNA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NuCyRNA Therapeutics's valuation, stock price, and market status.